Dynavax Technologies Corporation

(DVAX)

By |

Profile

Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The Company is engaged in the development for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer.

Contact Information

Website: www.dynavax.com
Main Phone: +1 510 848-5100
Address: 2929 Seventh Street
Address 2: Suite 100
State: CA
City / Town: Berkeley
Country: USA
Postal Code: 94710-2753

Issuer Information

Exchange: NSC
Employees: 234
NAICS: Pharmaceutical P
$ 4.65 ($ 0.15) (-3.13%)
Last Price 4.65 Change $ -0.15 Change % -3.13 Tick N/A
Bid 4.60 Bid Size 1,600.00 Ask 4.70 Ask Size 1,500.00
Open 4.80 High 5.00 Low 4.60 Prev Close 4.80
Last Trade Volume 1.9 mi 52 Wk Hi 29.86 52 Wk Low 3.20
Market Cap 179.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 38,527,660.00 EPS (TTM) -3.17 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 6
Number of Buys 1 6
Number of Sells 0 0
Net Activity 1452 6302
Last 10 Buys Shares
Robert Janssen 1,000
Eddie Gray 1,000
Eddie Gray 1,000
Robert Janssen 1,000
Robert Janssen 1,000
Eddie Gray 1,000
Peggy V. Phillips 1,000
Arnold L. Oronsky 1,000
Daniel L. Kisner 1,000
Arnold L. Oronsky 1,000
Last 10 Sell Shares
Robert L. Coffman 1,000
Mark Kessel 1,000
Robert L. Coffman 1,000
Robert L. Coffman 1,000
Robert L. Coffman 1,000
Jennifer Lew 1,000
Robert L. Coffman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 45 45 45 45
Low Target Price Estimate 17 17 17 17
Mean Target Price Estimate 32.25 32.25 32.25 35.67
Standard Deviation 14.86 14.86 14.86 16.17
Date of Most Recent Estimate 08/08/16 05/10/16 05/10/16 08/08/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 2 2 2